What happened today with Schering-Plough (SGP) is exactly why I have never bought a pharmaceutical stock and don’t plan to. I’ve always had this belief that every pharma company was one FDA study away from a 20% drop or worse and I had been meaning to write a blog post about this for a . . . → Read More: Drug Stocks